Lysozyme in the serum, urine and peripheral blood leukocytes in patients with immunocytoma.
Lysozyme activity was determined in the serum, urine and leukocytes of 53 patients with immunocytoma and 24 patients with lymphoproliferative syndromes without associated monoclonal gammapathy. In patients with multiple myeloma the frequency of low serum lysozyme activity and high leukocyte lysozyme activity was higher. In the cases with renal failure, lysozyme activity was raised in serum and urine, and the 24-hour urinary lysozyme excretion was increased. In 7 patients with increased urinary lysozyme excretion no clinical or laboratory evidence of renal complications was found. Relative monocytosis in peripheral blood was observed in half of the cases of multiple myeloma, and in these patients also in about half of the cases the lysozyme activity was raised in the leukocytes and urine, and the 24-hour urinary lysozyme excretion was increased. In patients with Hodgkin's disease, lymphosarcoma and chronic lymphatic leukemia the frequency of low serum lysozyme activity was increased.
D000328:Adult; D000368:Aged; D006801:Humans; D007674:Kidney Diseases / Q000201:enzymology; D007676:Kidney Failure, Chronic / Q000201:enzymology / Q000209:etiology; D007962:Leukocytes / Q000201:enzymology; D008232:Lymphoproliferative Disorders / Q000201:enzymology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000201:enzymology*; D009113:Muramidase / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008258:Waldenstrom Macroglobulinemia / Q000201:enzymology*
D009113:Muramidase